News and Resources
News and resources
IFFIm raises more than US$ 2 billion to support life-saving immunisation programmes in poorest countries
The International Finance Facility for Immunisation (IFFIm) satisfies strong demand for ethical investments and helps ensure children are vaccinated.
IFFIm’s inaugural sterling offering raises GBP 266 million for vaccine programmes
Retail and institutional investors welcome the unique opportunity to make an investment that protects millions of lives against preventable diseases. London, 15 May 2009 - The International Finance Facility for Immunisation Company (IFFIm) successfully raised more than GBP 266 million in five-year funds from retail and institutional investors. The...
Mitsubishi UFJ Financial Group expected to offer 'Vaccine Bonds' to Japanese investors
Children in the world's poorest countries could benefit from a lifetime of protection from vaccine-preventable diseases thanks to the proposed sale next month of Vaccine Bonds to Japanese retail investors by Mitsubishi UFJ Financial Group.
Innovative Vaccine Investment ISA will help save children's lives
Investors are being offered an opportunity to save money and help save lives with a new Vaccine Investment ISA which aims to raise £50 million to vaccinate children in the world’s poorest countries.
Vaccine bonds give Japanese retail investors a special investment opportunity
Vaccine bonds offered to Japanese retail investors in three currencies will raise USD 429 million equivalent to help pay for health and immunisation programmes in the world’s poorest countries.
'Vaccine bonds' offer Japanese savers an ethical investment
Vaccine bonds will offer Japanese investors a fixed rate of return plus an opportunity to see their money used to help immunise children in the world's poorest countries.
With new 'Vaccine Bonds' Japanese Investors will have the opportunity to save more children’s lives in the poorest countries of the world
New "Vaccine Bonds" expected to be offered in Japan by Daiwa Securities Group next year aim to accelerate immunisation of children in the world's poorest countries against deadly diseases. These new Vaccine Bonds would be the second initiative of its kind in Japan to use the capital markets to raise funds for a specific development purpose. [Englis...
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.